To Compare Efficacy and Safety of CT-P39 and EU-approved Xolair in Patients With Chronic Spontaneous Urticaria

计划入组 634 人 · 首次发布于 2020 年 6 月 11 日

A Study to Compare Efficacy and Safety of CT-P55 and Cosentyx in Patients With Moderate to Severe Psoriasis

计划入组 153 人 · 首次发布于 2024 年 10 月 8 日

A Study to Compare Efficacy and Safety of CT-P47 and RoActemra in Patients With Rheumatoid Arthritis

计划入组 471 人 · 首次发布于 2022 年 8 月 5 日

EU-251

EU-129

EU-5148

Isr Immune System Regulation AB

Sweden

Dymicron EU GmbH

Germany

Lantheus EU Ltd.

Ireland

EU Clinical Trial Regulation Mandates Posting of Interim Results, Raising Transparency Standards

Transitioning Ongoing Studies to the EU Clinical Trial Regulation

EU Clinical Trial Regulation Aims for Harmonization and Oversight